Arginine vasopressin V1a receptor antagonist impairs maternal memory in rats

被引:40
作者
Nephew, Benjamin C. [1 ]
Bridges, Robert S. [1 ]
机构
[1] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA
关键词
maternal behavior; AVP; neuropeptide; amygdala; social recognition;
D O I
10.1016/j.physbeh.2008.05.016
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Primiparous female rats rapidly respond to foster pups following an extended separation from pups after an initial maternal experience. This consolidation of maternal behavior has been referred to as maternal memory. The neurochemical regulation of maternal memory is not clearly understood. One neuropeptide that may mediate maternal memory is arginine vasopressin (AVP), a neuropeptide which is modulated around the time of parturition and has an established role in learning and memory processes. Thus, the present studies examine the possible involvement of AVP in the establishment of maternal memory in female rats. Pregnant rats were implanted with chronic cannulae connected to subcutaneous osmotic minipumps filled with a V1a receptor antagonist [d(CH2)5Tyr(Me)AVP, 0.1-12.5 ng/h] or saline vehicle which were chronically infused either into the lateral ventricles or bilaterally into the medial amygdala beginning on day 18 of gestation. Both the osmotic pumps and the newborn pups were removed 24 h following parturition. The effects of the V1a antagonist treatments on social recognition and maternal behavior were measured following parturition and maternal memory was assessed following a ten day separation from pups. Whereas none of the AVP treatments affected the initial establishment of maternal behavior postpartum, maternal memory was impaired in rats infused into the amygdala with the AVP antagonist (1.25 and 12.5 ng/h). Social recognition was not impaired by intracerebroventricular infusion of either the 0.1 or 1.0 ng/h dose of the V1a antagonist. The present results suggest a role for medial amygdaloid V1a receptors in the establishment of maternal memory. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:182 / 186
页数:5
相关论文
共 50 条
  • [21] Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema
    Taya, Keisuke
    Gulsen, Salih
    Okuno, Kenji
    Prieto, Ruth
    Marmarou, Christina R.
    Marmarou, Anthony
    INTRACRANIAL PRESSURE AND BRAIN MONITORING XIII: MECHANISMS AND TREATMENT, 2008, 102 : 425 - 429
  • [22] Estrogen receptor-alpha knockouts and maternal memory in nulliparous rats
    Gallagher, J. M.
    Nephew, B. C.
    Poirier, G.
    King, J. A.
    Bridges, R. S.
    HORMONES AND BEHAVIOR, 2019, 110 : 40 - 45
  • [23] Distribution of brain oxytocin and vasopressin V1a receptors in chimpanzees (Pan troglodytes): comparison with humans and other primate species
    Christina N. Rogers Flattery
    Daniel J. Coppeto
    Kiyoshi Inoue
    James K. Rilling
    Todd M. Preuss
    Larry J. Young
    Brain Structure and Function, 2022, 227 : 1907 - 1919
  • [24] Distribution of brain oxytocin and vasopressin V1a receptors in chimpanzees (Pan troglodytes): comparison with humans and other primate species
    Flattery, Christina N. Rogers
    Coppeto, Daniel J.
    Inoue, Kiyoshi
    Rilling, James K.
    Preuss, Todd M.
    Young, Larry J.
    BRAIN STRUCTURE & FUNCTION, 2022, 227 (05) : 1907 - 1919
  • [25] Maternal separation interferes with developmental changes in brain vasopressin and oxytocin receptor binding in male rats
    Lukas, M.
    Bredewold, R.
    Neumann, I. D.
    Veenema, A. H.
    NEUROPHARMACOLOGY, 2010, 58 (01) : 78 - 87
  • [26] Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism
    S-J Kim
    L J Young
    D Gonen
    J Veenstra-VanderWeele
    R Courchesne
    E Courchesne
    C Lord
    B L Leventhal
    E H Cook Jr
    T R Insel
    Molecular Psychiatry, 2002, 7 : 503 - 507
  • [27] Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism
    Kim, SJ
    Young, LJ
    Gonen, D
    Veenstra-VanderWeele, J
    Courchesne, R
    Courchesne, E
    Lord, C
    Leventhal, BL
    Cook, EH
    Insel, TR
    MOLECULAR PSYCHIATRY, 2002, 7 (05) : 503 - 507
  • [28] Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells
    Pastrian, Maria B.
    Guzman, Fanny
    Garona, Juan
    Pifano, Marina
    Ripoll, Giselle V.
    Cascone, Osvaldo
    Ciccia, Graciela N.
    Albericio, Fernando
    Gomez, Daniel E.
    Alonso, Daniel F.
    Iannucci, Nancy B.
    MOLECULAR MEDICINE REPORTS, 2014, 9 (06) : 2568 - 2572
  • [29] Luminal arginine vasopressin stimulates Na+-H+ exchange and H+-ATPase in cortical distal tubule via V1 receptor
    BarretoChaves, MLM
    deMelloAires, M
    KIDNEY INTERNATIONAL, 1997, 52 (04) : 1035 - 1041
  • [30] Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury
    Krieg, Sandro M.
    Trabold, Raimund
    Plesnila, Nikolaus
    JOURNAL OF NEUROTRAUMA, 2017, 34 (07) : 1329 - 1336